Chronic obstructive pulmonary disease (COPD)

MHRA approves dupilumab for treatment of uncontrolled COPD

The regulator has granted marketing authorisation for a subcutaneous injection as an add-on maintenance treatment for adults with uncontrolled COPD.…

Bringing high-quality diagnostics for COPD and asthma to north Wales

As a pharmacist prescriber at a community diagnostic respiratory hub in South Denbighshire, North Wales, Kevin Parvin explains why the hub is needed and how it is benefiting patients.…

Greener inhaler propellant is therapeutically equivalent to traditional alternatives, study results suggest

Study authors reported overall bioequivalence between inhalers that use HFA-152a as a propellant and traditionally used devices with HFA-134a as a propellant.…

Case-based learning: chronic breathlessness in adults

The causes and management of breathlessness in adults, with a focus on chronic breathlessness.…

Pulmonary hypertension: recognition, diagnosis and management

An overview of the pathogenesis, recognition, diagnosis and treatment of pulmonary hypertension.…

Monoclonal antibody found to improve COPD outcomes, trial results suggest

The monoclonal antibody treatment dupilumab was found to reduce the annual rate of moderate or severe exacerbations of chronic obstructive pulmonary disease when compared with placebo.…

NHS develops dashboard to identify possible over-prescribing of prednisolone

The dashboard calculates the total cumulative dose of prednisolone prescribed to patients in England in the past 12 months, allowing those at risk to be considered for alternative treatment methods.…

More than 90% of lung disease patients say community pharmacy services are vital, survey finds

Results of a survey by the Taskforce for Lung Health found that patients valued community pharmacies because they are close to home, there is no need to make an appointment and they have convenient opening times.…

Chronic obstructive pulmonary disease: diagnosis and management

Early diagnosis and medicines optimisation are fundamental to ensure timely and appropriate treatment of chronic obstructive pulmonary disease and improve a patient’s quality of life.…

Blue, brown and now green

The ‘NHS long-term plan’ has called for a shift towards inhalers with a lower carbon footprint.…